Arkolith/Insider Trading/IMMX/Form 4

Morris Gabriel S

CFO, DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Jun 10, 2024
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2024Buy(P)3K$2.12$5K286K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-023288) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML